Follow The Filings

KRRO Korro Bio

Korro Bio earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 11 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by KRRO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All KRRO insider trades
  • $20.8M bought by 10 insiders
  • None no sales outside a trading plan
  • $5.3M sold by 2 insiders under 10b5-1 plans
  1. Jean Francois Formela Director
    Planned sale
    $686K 48,690 shares at $14.09 27% of stake
    Traded Sep 11–14 Filed Sep 15
  2. Oliver Dolan Senior Vice President, Finance
    Planned sale
    $69 5 shares at $13.72 <0.1% of stake
    Traded Sep 11 Filed Sep 14
  3. Oliver Dolan Senior Vice President, Finance
    Planned sale
    $99K 7,353 shares at $13.51 31% of stake
    Traded Sep 8–9 Filed Sep 10
  4. Jean Francois Formela Director
    Planned sale
    $4,188 300 shares at $13.96 0.2% of stake
    Traded Aug 26 Filed Aug 28
  5. Jean Francois Formela Director
    Planned sale
    $399K 28,468 shares at $14.00 17% of stake
    Traded Aug 19 Filed Aug 21
  6. Jean Francois Formela Director
    Planned sale
    $30K 2,143 shares at $13.96 1.4% of stake
    Traded Aug 11 Filed Aug 13
  7. Lynx1 Capital Management LP 10% owner, +1 joint filer
    Buy
    $79K 6,684 shares at $11.79 +0.4% to stake
    Traded Aug 6–10 Filed Aug 13
  8. Jean Francois Formela Director
    Planned sale
    $1.5M 110,023 shares at $14.02 43% of stake
    Traded Jul 2–6 Filed Jul 7
  9. Jean Francois Formela Director
    Planned sale
    $2.5M 171,405 shares at $14.34 50% of stake
    Traded Jun 22–24 Filed Jun 24
  10. Jean Francois Formela Director
    Planned sale
    $40K 2,860 shares at $13.95 1.4% of stake
    Traded May 28 Filed Jun 1
  11. Lynx1 Capital Management LP 10% owner, +1 joint filer
    Buy
    $5,512 520 shares at $10.60 +<0.1% to stake
    Traded Mar 31 Filed Apr 2
  12. Rick Yang 10% owner
    Buy
    $2.3M 207,100 shares at $11.11 +19% to stake
    Traded Mar 10 Filed Mar 12

Also filed in the last 12 months, not counted as buying or selling: 11 stock grants and 6 sales to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 13 shown.

Filed Form Detail Links
8-K 8.01,9.01
8-K 8.01,9.01
8-K 8.01
SCHEDULE 13G/A —
8-K 1.01,2.02,3.02,9.01
10-Q
SCHEDULE 13D/A —
SCHEDULE 13G —
8-K 5.07
8-K 8.01,9.01
SCHEDULE 13G/A —
424B3
10-Q

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.